FOCL
EDAP TMS S.A. American Depositary Shares
NASDAQ · Healthcare · Medical - Specialties · FR
$4.15
−0.48%Aug 13, 2026, 00:00 UTC
EDAP TMS SA announced a public offering expected to raise gross proceeds of $40 million.
Aug 13, 2026, 00:00 UTC
EDAP TMS SA reported Q2 2026 revenue of $13.2 million, up 39% year-over-year, with a net loss of $14.5 million and diluted EPS of -$0.39.
Jun 1, 2026, 19:06 UTC
Edap Tms held its 2026 FocalTherics Investor Day to unveil its strategic pivot toward becoming a pure-play robotic focal therapy company, centered on its Focal One robotic HIFU platform for prostate cancer and future indications.
Source: